IDO1 and neoplasm: CD3-, CD4-, CD8-, CD20-, FOXP3-, ICOS-, IDO-1- (tumour and stroma) and PD-L1- (tumour and stroma) expressing cells were evaluated using singleplex IHC and quantified for use in survival analysis as described in Fig. 1.